|
JRC Publications Repository >
Browsing by Author SENEKOWITSCH-SCHMIDTKE R.
Showing results 5 to 22 of 22
| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type | | 2005 | Cell Death Triggered by Alpha-emitting 213Bi-immunoconjugates in HSC45-M2 Gastric Cancer Cells is different from Apoptotic Cell Death. | SEIDL C.; SCHROECK H.; SEIDENSCHWANG S.; BECK R.; SCHMID E.; ABEND M.; BECKER K.-F.; APOSTOLIDIS CHRISTOS; NIKULA Tuomo; KREMMER E., et al | Articles in Journals |
| 2003 | Comparison of the Radiotoxicity of two Alpha-Particle-Emitting Immunoconjugates, Terbium-149 and Bismut-213, Directed against a Tumor-Specific, Exon 9 Deleted (d99) E-Cadherin Adhesion Protein. | MIEDERER M.; SEIDL C.; BEYER G.; CHARLTON D.e.; VRANJES-DURIC S.; COMOR J.j.; HUBER Roswitha; NIKULA T.; APOSTOLIDIS Christos; SCHUMACHER C., et al | Articles in Journals |
| 2000 | Cytotoxicity of the alpha Emitter 213-Bi Coupled to a Specific Antobody. | MIEDERER M.; NIKULA T.; BRANDES K.; HANDSCHUH G.; ADAM C.; SCHUMACHER C.; APOSTOLIDIS Christos; BRECHBIEL M.; SCHMID E.; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2008 | Development and Evaluation of Peptidic Ligands Targeting Tumor-associated Urokinase Plasminogen Activator Receptor (uPAR) for Use in Alpha-emitter Therapy of Disseminated Ovarian Cancer | KNOER S.; SATO S.; HUBER T.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHMITT M.; KESSLER H.; SENEKOWITSCH-SCHMIDTKE R.; MAGDOLEN V.; SEIDL C. | Articles in Journals |
| 2012 | Die intravesikale Radioimmuntherapie mit Bi-213-anti-EGFR Immunkonjugaten verursacht keine Schäden am Urothel | MÜLLER Felix; SEIDL C.; WEIRICH G; RÖTZER S; FAZEL J; FRANK Annette; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2010 | Differential Gene Expression Triggered by Highly Cytotoxic a- Emitter-immunoconjugates in Gastric Cancer Cells | SEIDL C.; PORT M.; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.; ABEND M. | Articles in Journals |
| 2012 | Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest | VALLON M.; SEIDL C.; BLECHERT B.; LI Zhoulei; GILBERTZ K.-P.; BAUMGART Anja; AICHLER M; FEUCHTINGER A; GAERTNER F. C.; BRUCHERTSEIFER Frank, et al | Articles in Journals |
| 2005 | Fractionated Locoregional Low-Dose Radioimmunotherapy Improves Survival in a Mouse Model of Diffuse Type Gastric Cancer Using A 213BI-conjugated Monoclonal Antibody | BLOECHEL S.; BECK R.; SEIDL C.; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R. | Articles in Journals |
| 2012 | High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneum | RAUCH C; SEIDL C.; SCHLAPSCHY M; SKERRA A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R. | Articles in Journals |
| 2001 | Highly Specific Tumor Binding of a 213Bi Labeled Monoclonal Antibody against Mutant E-Cadherin Suggests its Usefulness for Locoregional alpha-Radioimmunotherapy of Diffuse-Type Gastric Cancer. | SENEKOWITSCH-SCHMIDTKE R.; SCHUHMACHER C.; BECKER K.; NIKULA T.k.; SEIDL C.; BECKER I.; MIEDERER M.; APOSTOLIDIS Christos; ADAM C.; HUBER Roswitha, et al | Articles in Journals |
| 2009 | In vitro and in vivo comparison of 226Th and 213Bi-labelled radioconjugates for target alpha therapy | BRUCHERTSEIFER Frank; MORGENSTERN Alfred; FRIESEN CLAUDIA; ROSCHER MAREIKE; MILTNER E.; PFOST B.; SENEKOWITSCH-SCHMIDTKE R.; ABBAS Kamel; APOSTOLIDIS Christos | Contributions to Conferences |
| 2001 | Lysine Protection against Bismuth Accumulation in the Kidneys when Using 213-Bi-DTPA-MAB. | NIKULA T.; APOSTOLIDIS Christos; MOLINET Roger; CARLOS-MARQUEZ R.; BRANDES K.; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2007 | Non-invasive Visualisation of the Development of Peritoneal Carcinomatosis and Tumour Regression After 213Bi-radioimmunotherapy Using Bioluminescence Imaging | BUCHHORN H.m.; SEIDL C.; BECK R.; SAUR D.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R. | Articles in Journals |
| 2009 | Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAb | PFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2012 | Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis | ESSLER M.; GAERTNER F. C.; NEFF Frauke; BLECHERT B.; SENEKOWITSCH-SCHMIDTKE R.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SEIDL C. | Articles in Journals |
| 2009 | Therapeutic efficacy of intravesical -radioimmunotherapy with Bi-213-anti-EGFR-MAb in a human bladder cancer nude mouse model | PFOST B.; SEIDL C.; AUTENRIETH M.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2009 | Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide
213Bi-DTPA-[F3]2 into the Nucleus of Tumor Cells | DRECOLL E.; GAERTNER F. C.; MIEDERER M.; BLECHERT B.; VALLON M.; MÜLLER J.; ALKE A.; SEIDL C.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred, et al | Articles in Journals |
| 2000 | Tumor Binding and Therapeutic Efficacy of 213-Bi Labeled Mutation Specific Monoclonal Antobody in a Human Intraperitoneal Gastric Cancer Model. | SENEKOWITSCH-SCHMIDTKE R.; FISCHER K.; SCHUMACHER C.; BECKER I.; BECKER K.; APOSTOLIDIS Christos; NIKULA T.; SCHWAIGER M. | Contributions to Conferences |
Showing results 5 to 22 of 22
|
